04:53 PM EDT, 05/14/2024 (MT Newswires) -- Arcutis Biotherapeutics ( ARQT ) reported a Q1 loss Tuesday of $0.32 per diluted share, compared with a loss of $1.31 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.73.

Revenue for the quarter that ended March 31 was $49.6 million, up from $2.8 million a year earlier.

Analysts surveyed by Capital IQ expected $15.1 million.

Shares of the company were up about 15% in recent after-hours activity.

Price: 9.27, Change: +1.14, Percent Change: +14.02